Navigation Links
PET Scans Helpful, But Not Definitive for Alzheimer's Diagnosis
Date:1/28/2013

By Steven Reinberg
HealthDay Reporter

MONDAY, Jan. 28 (HealthDay News) -- While there's still no definitive means of diagnosing Alzheimer's disease in living patients, PET scan technology may help suggest the onset of the disease. Now, experts are issuing new guidance on which patients might stand to benefit most from the expensive scans.

Amyloid brain plaque is considered one hallmark of Alzheimer's disease. With PET (positron emission tomography) imaging, amyloid can be identified while patients are still alive.

According to the guidelines, people who should be considered for a scan include the following:

  • People with persistent or progressive unexplained memory problems or confusion and those with problems on standard tests of thought and memory.
  • People with possible Alzheimer's, but whose symptoms don't present in the usual way.
  • People with progressive dementia before age 65.

On the other hand, PET amyloid scanning is not appropriate for people over 65 who are already known to have Alzheimer's, the guidelines say. Moreover, people who do not have any symptoms or with little medical evidence to support a diagnosis will not benefit from the scan.

The finding of brain amyloid in itself does not constitute a diagnosis of Alzheimer's dementia, the guidelines emphasize. It's just one tool to be used along with information from the patient's history and clinical examination.

"Amyloid imaging is not for every patient with Alzheimer's disease or with memory problems or even the 'worried well,'" said Maria Carrillo, vice president for medical and scientific relations at the Alzheimer's Association and guideline co-author.

Developed jointly by the Society of Nuclear Medicine and Molecular Imaging and the Alzheimer's Association, the guidelines were published online Jan. 28 in Alzheimer's & Dementia. The task force reviewed scientific literature and considered clinical scenarios.

These guidelines are particularly timely, Carrillo said, because most patients with dementia are 65 and older, and an advisory committee of the U.S. Centers for Medicare and Medicaid will be considering this topic on Jan. 30 to decide whether or not the cost of these scans will be covered under the programs.

PET scans can cost anywhere from $3,000 to $6,000 or more, she said.

"Amyloid imaging is appropriate for select use and is really limited to increase certainty of a diagnosis when there are uncertain conditions," Carrillo said. In these cases, imaging helps because it can aid the doctor in deciding what treatment should be given, she said.

For patients with persistent or progressing memory or thinking problems, the test can increase the certainty that they are dealing with an Alzheimer's type of dementia.

If there is no plaque in the brain, the doctor should then look for other causes of the problem such as small strokes or another type of dementia, she said.

Although little effective treatment for Alzheimer's exists, it's important for patients to know what they are dealing with, Carrillo said. "For us as a patient advocacy group, that's critical," she said. Many people are relieved to know even if it's a bad diagnosis, she said.

"What comes with that is not only the relief, but the beginning of not only a medical plan, but planning for the future," Carrillo said. "Even talking about the possibility of joining a clinical trial," she said.

Until recently, amyloid brain scans have mostly been used in research to determine which patients can be part of clinical trials and whether or not treatments are having results.

"These are the first guidelines for clinical use of amyloid imaging," said Dr. Sam Gandy, associate director of the Mount Sinai Alzheimer's Disease Research Center, in New York City.

This has been coming since 2002, but now the promise has been realized and anyone who should have amyloid imaging and can get to a nuclear medicine unit will be able to have the scan, he said.

"Another milestone is that never again will a doctor have to say, 'we can't tell for sure until your loved one dies and we look at the brain during an autopsy,'" Gandy said.

"On the downside, while scanning of healthy 'worried well' people is explicitly discouraged and disapproved, that is already happening and I am not sure that these guidelines will attenuate that demand," he said. "Persistent people will always find someone to write the script. So, this challenge remains."

More information

To learn more about Alzheimer's disease, visit the U.S. Department of Health and Human Services.

SOURCES: Maria Carrillo, Ph.D., vice president, medical and scientific relations, Alzheimer's Association; Sam Gandy, M.D., Ph.D., associate director, Mount Sinai Alzheimer's Disease Research Center, New York City; Jan. 28, 2013, Alzheimer's & Dementia, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Signs of Brain Damage Show Up in Scans of Living, Retired NFL Players
2. No need for routine repeated CT scans after mild head trauma, reports neurosurgery
3. Paired CT scans catch chemo-killing of liver tumors in real time
4. Brain Scans Might Help Spot Risk for Bipolar Disorder
5. MRIs reveal signs of brain injuries not seen in CT scans, UCSF/SFGH researchers report
6. More U.S. Kids Get High-Radiation Scans, Study Says
7. Experts recommend closer scrutiny of radiation exposure from CT scans
8. Study: Chest CT Scans May Increase Breast Cancer Risk
9. Scans Spot Brain Changes in Patients With Concussion Syndrome
10. Advanced CT scans accurately assess coronary blockages
11. Unexpected findings at multi-detector CT scans: Less reason to worry
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PET Scans Helpful, But Not Definitive for Alzheimer's Diagnosis
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: